Avtal | $24,000,000 | (Mar 20, 2026)
Parallel(FRANCE) | $20,000,000 | (Mar 20, 2026)
Claros | $30,000,000 | (Mar 20, 2026)
Certified by Founder
Lodge
ExcepGen
start up
United States
- San Francisco, CA
- 25/08/2023
- Unknown
- $4,000,000
ExcepGen is a venture-backed, early stage biotechnology company located in San Francisco. The company is focused on solving fundamental underlying problems in drug discovery and applying those solutions to create a new generation of therapeutics.
- Industry Biotechnology Research
- Website https://www.excepgen.com/
- LinkedIn https://www.linkedin.com/company/excepgen/about/
Related People
Thomas FolliardCo Founder
United States -
San Francisco, California
I am involved in a variety of activities and responsibilities having to do with making drugs easier to discover.
Specialties: foundational engineering of biology, next-generation drugs and drug discovery, starting organizations.
Latent | $80,000,000 | (Mar 20, 2026)
Corridor | $25,000,000 | (Mar 20, 2026)
RunSybil | $40,000,000 | (Mar 20, 2026)
PADO AI | $6,000,000 | (Mar 20, 2026)
Edra | $30,000,000 | (Mar 20, 2026)
Chalkie AI | $4,000,000 | (Mar 20, 2026)
Deeptune | $43,000,000 | (Mar 20, 2026)
SetSale | $2,000,000 | (Mar 19, 2026)
Laminar (YC S24) | $3,000,000 | (Mar 19, 2026)